Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Tirode

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Cell Reports|January 19, 2023
VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesisSarah Watson, Collette A LaVigne, Lin Xu, et al.
Molecular Cancer Therapeutics|July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress ResponseKathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
The Journal of Pathology|October 29, 2024
Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1::PLAG1 gene fusionZiyad Alsugair, Marie Donzel, Nicolas Macagno, et al.
Head and Neck Pathology|December 29, 2025
Histomolecular Features of a Rare Subtype of Pleomorphic Adenoma Characterised by Abundant Lymphoid Stroma and HMGA2 RearrangementsZiyad Alsugair, Seddig Momenkhan, Marie Donzel, et al.
Histopathology|November 20, 2024
Recurrent GRHL fusions in a subset of sebaceoma: microscopic and molecular characterisation of eight casesMélanie Legrand, Baptiste Louveau, Nicolas Macagno, et al.
Nature Medicine|June 29, 2010
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexityFrédéric Chibon, Pauline Lagarde, Sébastien Salas, et al.
Science Advances|February 27, 2026
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in <i>MYOD1</i>-mutant rhabdomyosarcomaJosephine K Dermawan, Fabio Vanoli, Henry Traux de Wardi, et al.
Histopathology|May 18, 2023
Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiationThibault Kervarrec, Daniel Pissaloux, Sandrine Paindavoine, et al.
Human Pathology|August 1, 2024
Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insightsZiyad Alsugair, Charles Lépine, Françoise Descotes, et al.
Cancer Research Communications|September 14, 2023
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many CancersBoris Guyot, Flora Clément, Youenn Drouet, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Cell Reports|January 19, 2023
VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesisSarah Watson, Collette A LaVigne, Lin Xu, et al.
Molecular Cancer Therapeutics|July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress ResponseKathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
The Journal of Pathology|October 29, 2024
Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1::PLAG1 gene fusionZiyad Alsugair, Marie Donzel, Nicolas Macagno, et al.
Head and Neck Pathology|December 29, 2025
Histomolecular Features of a Rare Subtype of Pleomorphic Adenoma Characterised by Abundant Lymphoid Stroma and HMGA2 RearrangementsZiyad Alsugair, Seddig Momenkhan, Marie Donzel, et al.
Histopathology|November 20, 2024
Recurrent GRHL fusions in a subset of sebaceoma: microscopic and molecular characterisation of eight casesMélanie Legrand, Baptiste Louveau, Nicolas Macagno, et al.
Nature Medicine|June 29, 2010
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexityFrédéric Chibon, Pauline Lagarde, Sébastien Salas, et al.
Science Advances|February 27, 2026
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in <i>MYOD1</i>-mutant rhabdomyosarcomaJosephine K Dermawan, Fabio Vanoli, Henry Traux de Wardi, et al.
Histopathology|May 18, 2023
Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiationThibault Kervarrec, Daniel Pissaloux, Sandrine Paindavoine, et al.
Human Pathology|August 1, 2024
Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insightsZiyad Alsugair, Charles Lépine, Françoise Descotes, et al.
Cancer Research Communications|September 14, 2023
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many CancersBoris Guyot, Flora Clément, Youenn Drouet, et al.
Pageof 14